AACC TV: Spotlight on IVD Innovators

A banner that says, "AACC TV: Find out what's happening in labs today."

This series of short sponsored videos highlights some of the organizations at the cutting-edge of laboratory medicine and profiles their key research, technologies, and best practices.

The views, information, or opinions expressed during the following sponsored videos are solely those of the individuals involved and do not represent those of AACC.

Veredus Laboratories

COVID-19 Biosurveillance in Singapore and Beyond

Established during the H5N1 epidemic, Singapore’s Veredus Laboratories aims, not just to provide the fastest and most accurate testing for a wide range of diseases, but to work with partners to place these tests where they’re needed most—in airports, schools, and even homes—as well as to keep track of and predict how the next outbreak might occur.

FBB Biomed

Magic Targets for Paul Ehrlich’s Magic Bullets

FBB Biomed proposes a fundamentally new approach to diagnostics. By looking at over-expression of RNA following the body’s immune response to diseases ranging from multiple sclerosis to dengue fever, they hope to discover the language through which the second arm of the immune system—known as innate immunity—speaks.

LSI Medience Corporation

The LSI Medience Corporation has developed PATHFAST. PATHFAST is a new POCT (Point of Care Testing) system that allows for highly-sensitive and high performance measurements in conjunction with panel testing. A point of care testing (POCT) device suitable for use in conjunction with panel testing provides highly sensitive, high-performance measurements, while at the same time offering the speed and ease-of-use demanded in the POCT environment. PATHFAST has been used all around the globe, improving health care in many different cities around the world.

Archer DX

Invitae is a leading medical genetics company with world-class germline and somatic testing in a single, comprehensive platform. ArcherDX was acquired by Invitae in October 2020 and brings the somatic oncology offerings to the platform. ArcherDX's technologies are built on its proprietary Anchored Multiplex PCR (AMP™) chemistry that enables testing services for disease risk, therapy optimization and personalized cancer monitoring to advance precision approaches to cancer treatment.


Using NGS to Improve Patient Outcomes

MicroGenDx's technology and mission are improving and saving the lives of patients with serious and often chronic infections and diseases by using the latest science and the most precise diagnostic tool available to identify the cause of infection so that the most effective medicine can be prescribed to treat that infection. Thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX’s work.


Rising to the Challenge of COVID-19 Testing

Curative is a company born out of the pandemic after pivoting a sepsis diagnostics company with 9 people with a goal of improving US COVID-19 testing capacity. Over the past 6 months, Curative has grown to over 1,200 employees across three laboratories and has tested nearly 5 million people by September 2020.

University of Texas Medical Branch

Innovation to Save Lives

Laboratory Medicine can save and improve lives, and the technology and systems that it’s built around can have a fundamental impact on its ability to do so. Since 1989 the Division of Clinical Chemistry at University of Texas Medical Branch has been adopting new technology to improve its approach to clinical chemistry.

Longhorn Vaccines and Diagnostics

Leading Development and Innovation in Molecular Testing 

Longhorn Vaccines and Diagnostics, LLC is a closely held, veteran-owned company. With an emphasis on innovation, the company has developed unique, groundbreaking products for the molecular testing market that meet critical unmet needs in both the Developed and Developing World.

Clarity Lab Solutions

Innovative, Onsite Labs

More accessible and rapid testing is key in the Covid-19 response - especially at the world's busiest airports. Beginning in December 2020, Clarity Lab Solutions, in partnership with SG Blocks and Grimshaw, helped Los Angeles International Airport (LAX) develop a full, on-site rapid testing laboratory for its passengers and anyone needing access to COVID-19 testing.

Visby Medical

At Visby Medical researchers have produced a diagnostic tool simple and small enough that it can be used by anyone, anywhere, with current applications in COVID-19 and sexual health. Visby Medical is breaking through the barriers that prevent individuals from getting the care they need when they need it and allowing individuals to keep living their lives through challenging times.


Agendia arms patients and their physicians with the data they need to make breast cancer treatment decisions every step of the way, from initial diagnosis to cancer-free.